{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:29:55Z","timestamp":1778797795827,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-023-08943-y","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T18:01:53Z","timestamp":1701453713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan"],"prefix":"10.1007","volume":"51","author":[{"given":"Asad","family":"Ullah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibi Maryam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeb Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidra Tul","family":"Muntaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samiullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakif Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhlid H.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ijaz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"issue":"3","key":"8943_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249","journal-title":"Cancer J Clin"},{"issue":"Suppl 2","key":"8943_CR2","first-page":"S387","volume":"12","author":"BW Vabi","year":"2021","unstructured":"Vabi BW, Gibbs JF (2021) J.J.o.G.O. Parker. Implications of the Growing Incidence of Global Colorectal cancer 12(Suppl 2):S387","journal-title":"Implications of the Growing Incidence of Global Colorectal cancer"},{"issue":"2","key":"8943_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E et al (2023) Global burden of Colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72(2):338\u2013344","journal-title":"Gut"},{"issue":"19","key":"8943_CR4","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1158\/1078-0432.CCR-08-1596","volume":"14","author":"J-P Issa","year":"2008","unstructured":"Issa J-P (2008) Colon Cancer: it\u2019s CIN or CIMP. Clin Cancer Res 14(19):5939\u20135940","journal-title":"Clin Cancer Res"},{"issue":"2","key":"8943_CR5","first-page":"31","volume":"31","author":"DL Worthley","year":"2010","unstructured":"Worthley DL, Leggett BA (2010) Colorectal cancer: molecular features and clinical opportunities. Clin Biochemist Reviews 31(2):31","journal-title":"Clin Biochemist Reviews"},{"issue":"1","key":"8943_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2003.10.002","volume":"30","author":"JJ Laskin","year":"2004","unstructured":"Laskin JJ, Sandler AB (2004) Epidermal growth factor receptor: a promising target in solid tumours. Cancer Treat Rev 30(1):1\u201317","journal-title":"Cancer Treat Rev"},{"key":"8943_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-014-0244-8","volume":"12","author":"L Xu","year":"2014","unstructured":"Xu L et al (2014) Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and Metastasis of colorectal carcinoma via the MAPK and PI3K\/AKT pathway. J Translational Med 12:1\u201312","journal-title":"J Translational Med"},{"issue":"2","key":"8943_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E","volume":"182","author":"S M\u00e9nard","year":"2000","unstructured":"M\u00e9nard S et al (2000) Role of HER2 gene overexpression in breast carcinoma. J Cell Physiol 182(2):150\u2013162","journal-title":"J Cell Physiol"},{"issue":"6","key":"8943_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.currproblcancer.2018.07.001","volume":"42","author":"M Greally","year":"2018","unstructured":"Greally M, Kelly CM, Cercek A (2018) HER2: an emerging target in Colorectal cancer. Curr Probl Cancer 42(6):560\u2013571","journal-title":"Curr Probl Cancer"},{"key":"8943_CR10","doi-asserted-by":"crossref","unstructured":"Spano J et al (2005) Epidermal growth factor receptor signaling in Colorectal cancer: preclinical data and therapeutic perspectives. 16(2):189\u2013194","DOI":"10.1093\/annonc\/mdi057"},{"key":"8943_CR11","doi-asserted-by":"crossref","unstructured":"Citri A (2006) Y.J.N.r.M.c.b. Yarden, EGF\u2013ERBB signalling: towards the systems level. 7(7):505\u2013516","DOI":"10.1038\/nrm1962"},{"key":"8943_CR12","doi-asserted-by":"crossref","unstructured":"Du S et al (2022) Prognostic and therapeutic significance of a novel ferroptosis related signature in Colorectal cancer patients. 13(2):2498\u20132512","DOI":"10.1080\/21655979.2021.2017627"},{"key":"8943_CR13","doi-asserted-by":"crossref","unstructured":"Wieduwilt M, Moasser MJC (2008) and m.l. sciences, The epidermal growth factor receptor family: biology driving targeted therapeutics 65: p.\u00a01566\u20131584","DOI":"10.1007\/s00018-008-7440-8"},{"key":"8943_CR14","doi-asserted-by":"crossref","unstructured":"Maennling AE et al (2019) Molecular targeting therapy against EGFR family in Breast cancer: progress and future potentials. 11(12):1826","DOI":"10.3390\/cancers11121826"},{"key":"8943_CR15","doi-asserted-by":"crossref","unstructured":"Wang K et al (2019) N-methylparoxetine blocked autophagic flux and induced apoptosis by activating ROS-MAPK pathway in non-small cell lung cancer cells 20(14): p.\u00a03415","DOI":"10.3390\/ijms20143415"},{"issue":"3","key":"8943_CR16","first-page":"784","volume":"14","author":"MA Brown","year":"2022","unstructured":"Brown MA, Ried TJC (2022) Shifting the Focus of Signaling Abnormalities in Colon Cancer 14(3):784","journal-title":"Shifting the Focus of Signaling Abnormalities in Colon Cancer"},{"key":"8943_CR17","doi-asserted-by":"crossref","unstructured":"Nassiri M et al (2013) Genes and SNPs associated with non-hereditary and hereditary colorectal cancer 14(10): p.\u00a05609\u20135614","DOI":"10.7314\/APJCP.2013.14.10.5609"},{"key":"8943_CR18","doi-asserted-by":"crossref","unstructured":"Stefani C et al (2021) Growth factors, PI3K\/AKT\/mTOR and MAPK signaling pathways in Colorectal cancer pathogenesis: where are we now?. 22(19):10260","DOI":"10.3390\/ijms221910260"},{"issue":"6","key":"8943_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1155\/2013\/587682","volume":"34","author":"NR AbdRaboh","year":"2013","unstructured":"AbdRaboh NR et al (2013) HER1 R497K and HER2 I655V polymorphisms are linked to development of Breast cancer. Dis Markers 34(6):407\u2013417","journal-title":"Dis Markers"},{"key":"8943_CR20","doi-asserted-by":"crossref","unstructured":"Martinelli E et al (2020) Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic Colorectal cancer: challenges and future perspectives. 31(1):30\u201340","DOI":"10.1016\/j.annonc.2019.10.007"},{"key":"8943_CR21","doi-asserted-by":"crossref","unstructured":"Li R et al (2020) Chemotherapeutic effectiveness of combining cetuximab for metastatic colorectal cancer treatment: A system review and meta-analysis 10: p.\u00a0868","DOI":"10.3389\/fonc.2020.00868"},{"key":"8943_CR22","doi-asserted-by":"crossref","unstructured":"Uroog L et al (2020) Genetic variants of epidermal growth factor receptor (EGFR) and their association with colorectal cancer risk in North Indian population 19: p.\u00a0100681","DOI":"10.1016\/j.genrep.2020.100681"},{"key":"8943_CR23","doi-asserted-by":"crossref","unstructured":"Wang W-S et al (2007) Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. 13(12):3597\u20133604","DOI":"10.1158\/1078-0432.CCR-06-2601"},{"key":"8943_CR24","doi-asserted-by":"crossref","unstructured":"Alanazi IO et al (2021) Association of HER1 and HER2 gene variants in the predisposition of colorectal Cancer 2021","DOI":"10.1155\/2021\/6180337"},{"key":"8943_CR25","doi-asserted-by":"crossref","unstructured":"Jaka A et al (2014) Association between EGFR gene polymorphisms, skin rash and response to anti-EGFR therapy in metastatic Colorectal cancer patients. 23(10):751\u2013753","DOI":"10.1111\/exd.12510"},{"key":"8943_CR26","doi-asserted-by":"crossref","unstructured":"Martinelli M et al (2011) The EGFR R521K polymorphism influences the risk to develop Colorectal cancer. 8(2):61\u201365","DOI":"10.3233\/DMA-2011-0826"},{"key":"8943_CR27","unstructured":"Liang X et al (2009) Association between HRE-2 gene polymorphism at codon 655 and genetic susceptibility of Colorectal cancer. 26(3):302\u2013305"},{"key":"8943_CR28","doi-asserted-by":"crossref","unstructured":"Mustafa OH et al (2013) Allele frequencies of the epidermal growth factor receptors polymorphism R521K in Colorectal cancer patients and healthy subjects indicate a risk-reducing effect of K521 in Syrian population. 5(3):202","DOI":"10.4103\/1947-2714.109189"},{"key":"8943_CR29","doi-asserted-by":"crossref","unstructured":"McKay J et al (2002) c-erbB-2 is not a major factor in the development of Colorectal cancer. 86(4):568\u2013573","DOI":"10.1038\/sj.bjc.6600127"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08943-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:18:36Z","timestamp":1738700316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08943-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8943"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08943-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author\/s have no conflicting interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicting interest"}},{"value":"This study was conducted at Institute of Biotechnology and Genetic Engineering (IBGE), under the ethical approval (No: IBGE\/2022\/013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the patients and healthy controls were individually briefed about the aim and objectives of the study, written consent was taken before taking their data and blood samples.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}}],"article-number":"1"}}